Loading interface...

Erythego Gel

Manufactured byAkumentis Healthcare Ltd.
ContainsBrimonidine
Description
Erythego Gel is a topical gel containing Brimonidine as an active ingredient. It is used to reduce the symptoms of rosacea (a skin condition that causes flushing of the face and visible blood vessels). Erythego Gel works by contracting the blood vessels, hence reducing redness. Erythego Gel may cause some side effects such as mild irritation, itching, and burning sensation on the skin. Most of these symptoms occur for a short duration and get resolved with time. Consult your doctor if they remain for a long time or become worse. Erythego Gel is not recommended for use if you are allergic to it. Erythego Gel is for external use only. Apply a thin layer of the gel to the affected areas as instructed by the doctor. Wash and dry the affected area before application. Use it for the recommended duration to see maximum benefits. Erythego Gel is not recommended for use in children below 18 years of age. Inform your doctor if you are taking any other medicines as they might interact with this medicine and increase the risk of undesired effects. Consult your doctor if you are pregnant, or are breastfeeding before using Erythego Gel.

Side effects

Major & minor side effects for Erythego Gel

  • Redness of the skin
  • Burning, itching, and irritation of the skin
  • Skin rash
  • Pale skin

Uses of Erythego Gel

What is it prescribed for?

  • Rosacea
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of Erythego Gel can be observed within 30 minutes.
  • How long do the effects of this medicine last?
    The effect of Erythego Gel lasts for an average duration of 12 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendency has been reported for Erythego Gel.
  • Can this medicine be taken during pregnancy?
    Erythego Gel should only be used during pregnancy upon your doctor's recommendation.
  • Can this medicine be taken while breast-feeding?
    It is not known whether Erythego Gel passes into breast milk or if it could affect the nursing baby. Hence consult your doctor before using this medicine if you are breastfeeding.

Allergy

Avoid using Erythego Gel if you are allergic to it. Seek immediate medical attention if you notice any symptoms of allergic reactions such as severe itching, redness, skin irritation, or rash.
Warnings for special population

Pregnancy

Erythego Gel should only be used during pregnancy upon your doctor's recommendation.

Breast-feeding

It is not known whether Erythego Gel passes into breast milk or if it could affect the nursing baby. Hence consult your doctor before using this medicine if you are breastfeeding.
General warnings

Use in children

Erythego Gel is not recommended for use in children below 18 years of age as the safety and efficacy data are not clinically established.

Disease conditions

Erythego Gel should be used with caution if you have heart problems, depression, cerebral or coronary insufficiency (obstruction in blood vessels supplying blood to the brain or heart), Raynaud's syndrome (a condition that occurs due to decreased blood flow to the fingers or toes, causing them to feel numb and cold), low blood pressure, thrombangiitis obliterans (a rare condition in which the blood vessels in the hands and feet become inflamed and get blocked by blood clots), scleroderma (a condition in which the skin becomes hard and thick), or sjogren’s syndrome (a disorder that decreases the amount of moisture produced by the eyes and mouth, usually characterised by dry eyes and dry mouth). Inform your doctor if you have such conditions before using this medicine.

External use only

Erythego Gel is meant for use on the skin only. Avoid contact with the eyes, nose, and mouth. Rinse thoroughly with water in case of accidental contact.

Missed Dose

Apply the missed dose of Erythego Gel as soon as possible. Skip the missed dose if it is time for your next scheduled dose. Do not apply a double dose to make up for the missed one.

Overdose

As Erythego Gel is a topical preparation the risk of severe side effects due to an overdose is low. However, never use more than the recommended dose. Also, ingestion of this medicine may cause harm and an immediate medication intervention may be necessary in such cases.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Wash and dry the affected area before using Erythego Gel. Apply a thin layer of gel (pea-sized amount) to the affected area of the skin. Do not cover the application area with bandages or other coverings unless specifically instructed by the doctor. Erythego Gel is for external use only. Avoid contact with the eyes, nose, and mouth. In case of accidental contact, wash the area thoroughly with water.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Erythego Gel tightens the blood vessels and reduces the symptoms of rosacea.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Alpha adrenergic agonists, Topical anti-rosacea agents

Schedule

Schedule H

Galdermausa.com. 2021. [online] Available at: [Accessed 7 February 2021].

http://www.galdermausa.com/pi/mirvasopi.pdf

Pbm.va.gov. 2021. [online] Available at: [Accessed 7 February 2021].

https://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Brimonidine_Gel_MIRVASO_Monograph.pdf

Dailymed.nlm.nih.gov. 2021. DailyMed - MIRVASO- brimonidine tartrate gel. [online] Available at: [Accessed 7 February 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6a4353f-ae69-4214-901f-e5d42a6fbde7
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 25 Aug 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.